Colestipol (HCl)
Colestipol (HCl) is antihyperlipidimic agent. Chemically Colestipol (HCl) is a copolymer of diethylenetriamine and 1-chloro-2, 3-epoxypropane. Colestipol (HCl) is very large polymeric anion-exchange resins that is insoluble in water. Colestipol (HCl) is effective in reducing the high levels of cholesterol in blood.
Primary Characteristics
It is of Natural origin and belongs to Resin.
It belongs to Lipid lowering agents pharmacological group on the basis of mechanism of action.
Molecular Weight: 318.29 · Solubility in Alcohol: insoluble · Non-proprietary name: Colestipol (HCl) · pH: 6.

Pharmacokinetics
Elimination: renal excretion is < 0.05 %.
Advertisement
Indications
Colestipol (HCl) is primarily indicated in conditions like Atherosclerosis, Bile salt-induced diarrhoea, Digitalis toxicity, Digitoxin toxication, Familial hypercholesterolaemia, Hypercholesterolaemia, Partial biliary obstruction-induced pruritus, Prophylaxis of NSAID-associated gastric or duodenal ulcer, Prophylaxis of NSAID-associated gastric or duodenal ulcer.
Contraindications
Colestipol (HCl) is contraindicated in conditions like Intestinal obstruction, Diverticulitis, Anal fissure, Hernia.
Dosage
Colestipol (HCl)'s dosage details are as follows:
| Dose | Single Dose | Frequency | Route | Instructions |
|---|---|---|---|---|
| Adult Dosage | ||||
| 142.856 mg/kg | 142.856 mg/kg | Every 12h | PO | 2-16gm/day in divided doses |
| Paediatric Dosage (20kg) | ||||
| 0.375 g/kg | 0.375 g/kg | Every 24h | Oral | Increase 0.25g/kg every 2-3 Months |
| Neonatal Dosage (3kg) | ||||
| 0 – 0 | — | — | Not recomended in this age group | |
Drug Interactions
Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.
Side Effects
Colestipol (HCl) in overdosage may give rise to further complications which include Constipation .
The signs and symptoms that are produced after acute overdosage of Colestipol (HCl) are Intestinal obstruction.
Colestipol (HCl) is known to cause more or less tolerable side effects which are usually transient. These include Abdominal discomfort, Constipation , Diarrhea, Flatulence, Heart burn, Nausea, Vomiting .
Warnings / Precautions
Interference in Pathology
Colestipol (HCl) may interfere in the diagnosis of Increased Values for LFTs .
Available Brands
None recorded.
Storage Conditions
Drug Classification
- 1.12.6 — Lipid-regulating drugs /Anti-atheromas